Press Releases

SALT LAKE CITY--(BUSINESS WIRE)-- XableCath, a commercial-stage medical device company, announced today that it has demonstrated initial safety and efficacy of its unique catheters for use with chronic venous occlusions, commonly characterized by recalcitrant lesions that have historically proven difficult to cross with standard catheter technologies. XableCath catheters are FDA-cleared for use in the periphera

Read more...

HENDERSON, Nev.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that an overview of the company's business strategy and commercial and development-stage programs will be given at the Jefferies 2018 London Healthcare Conference being held i

Read more...

MORRISVILLE, N.C.--(BUSINESS WIRE)-- Aetna (NYSE: AET) today announced it has added Cone Health and

Read more...

PORTLAND, Ore.--(BUSINESS WIRE)-- NuScale Power is pleased to announce it has signed a memorandum of understanding (MOU) with Ontario Power Generation Inc. (OPG), Ontario&rsqu

Read more...

SCRANTON, Pa.--(BUSINESS WIRE)-- Carvana (NYSE: CVNA), a leading e-commerce platform for buying used cars, launched today in Scranton, with as-soon-as-next-day vehicle delivery,

Read more...

TARRYTOWN, N.Y.--(BUSINESS WIRE)-- Integrated healthcare provider Primary Health Care has joined forces with Siemens Healthineers to deploy more than 70 Atellica® Solution1 immunoassay and clinical chemistry analyzers. This marks Siemens Healthineers largest contract for in vitro diagnostics testing in Australia, and one of its most robust sales of the Atellica Solution. The analyzers are integra

Read more...

WINCHESTER, Va.--(BUSINESS WIRE)-- Trex Company, Inc. (NYSE:TREX) – High-performance, stellar looks and affordability in a composite deck board? It’s time to enhance your thinking. The newly re-engineered and expanded line of Trex Enhance® composite decking combines the ease, beauty and durability of Trex’s world-famous composite decking with pricing designed to put the pressure

Read more...

NEW ORLEANS--(BUSINESS WIRE)-- On Friday, November 16, Immunomic Therapeutics Inc. (ITI) Scientist Amit Adhikara will present at the Society for NeuroOncology 2018 Annual Meeting in New Orleans. The presentation will focus on Immunomic’s recently-expanded investigational UNiversal Intracellular Targeted Expression (UNITE™) platform and its application in immuno-oncology, specifically glioblastoma mu

Read more...

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte Corporation (Nasdaq:INCY) announced today that it will present at Evercore ISI HEALTHCONx on Wednesday, November 28, 2018 at 3:30 pm EST in Boston. The presentation will be webcast live and can be accessed at

Read more...

WASHINGTON--(BUSINESS WIRE)-- A phase 1b clinical trial shows that administering a concentrated dose of anti-CEA CAR-T cells precisely at the site of a solid tumor by means of

Read more...

HOLBROOK, N.Y.--(BUSINESS WIRE)-- Mobile Industrial Robots (MiR) reached production capacity for its new MiR500 autonomous mobile robots (AMRs) in its first month. With plans in place to deliver all current orders by the end of 2018, including the 40 percent purchased by U.S. manufacturers, the Denmark-based robotics manufacturer and industry first-mover today announced it would double production of the MiR500

Read more...

WINCHESTER, Va.--(BUSINESS WIRE)-- Trex Company, Inc. (NYSE:TREX), the world’s number-one brand of decking and railing and leader in high-performance, low-maintenance outdoor living products, and a leading national provider of custom-engineered railing systems, announced that its management will participate and host investor meetings at the following conferences:

Read more...

LEXINGTON, Mass.--(BUSINESS WIRE)-- Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will participate at the following upcoming inves

Read more...

DURHAM, N.C.--(BUSINESS WIRE)-- Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retina diseases and other diseases of the eye, today announced that Vicente Anido, Jr., Ph.D., Chairman and Chief Executive Officer, will present in a firesid

Read more...